A Study to Evaluate Pharmacokinetic Parameters of Eliglustat in Healthy Volunteers Who Are CYP2D6 Extensive or Poor Metabolizers
Clinical trial NCT06188325 · COMPLETED
Trial details
- NCT number
- NCT06188325
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2018-03-26
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.